Effects of Remimazolam on Intraoperative Blood Pressure Control in Interventional Cerebral Aneurysm Coil Embolization; A pilot study of a prospective randomized controlled trial

Korea University Anam Hospital0 个研究点目标入组 30 人开始时间: 待定最近更新: 2023年5月2日

适应症

试验速览

暂无简介。

•Patients over age 19 undergoing elective cerebral aneurysm coil embolization at Korea University hospital under general anesthesia, who have agreed to terms.

•Patients who have already been intubated and sedated before general anesthesia
•Patients without tracheal extubation after coil embolization
•Patients with hemodynamic instability, such as shock or coma
•Patients with hypersensitivity or specific reactions to narcotic drugs, including sevoflurane and remifentanil, and benzodiazepines
•Patients who are an absolute contraindication to the administration of remimazolam; Patients with acute narrow-angle glaucoma, patients with acute alcoholism with suppressed vital signs, patients with severe or acute respiratory failure, patients with genetic lactose intolerance such as galactose intolerance, patients with severe hypersensitivity to dextran 40
•Patients with mental retardation or difficulties in reading Korean
•Subjects who are vulnerable to research (research participants who are vulnerable to coercion or undue influence, or those who lack decision-making ability; pregnant women, fetuses/newborns, minors, those who lack decision-making ability, students, staff, voluntary decision to participate due to surrounding environment susceptible to)
•Patients unable to continuously monitor arterial blood pressure through the radial artery

发起方